2026-10-16 15:49:00 UTC#472886newconfirmednews
IBRX stock news
IBRX stock news. Deduplicated factual headlines, scored for importance, with entity sentiment and the sectors, countries, and asset classes affected. Updates open into the storyline.
See the full wire11 wire items
2026-10-15 22:38:00 UTC#468859newconfirmednews
H.C. Wainwright & Co. maintains $15.00 price target on ImmunityBio (IBRX)
2026-10-14 21:23:00 UTC#461914duplicateconfirmednews
ImmunityBio ANKTIVA FDA label expanded to include papillary-only BCG-unresponsive NMIBC
tradingviewimportance 0.30trust 0.70ImmunityBio, Inc. +0.80ANKTIVA +0.80U.S. Food and Drug Administration +0.50
2026-10-14 20:59:00 UTC#461817duplicateconfirmednews
FDA expands ImmunityBio's Anktiva indication for papillary-only BCG-unresponsive bladder cancer
dow_jonesimportance 0.40trust 0.90ImmunityBio, Inc. +0.60Anktiva +0.60U.S. Food and Drug Administration +0.20+1 entities
2026-10-14 20:18:00 UTC#461499duplicateconfirmednews
ImmunityBio receives FDA approval for ANKTIVA in papillary-only BCG-unresponsive NMIBC
tradingviewimportance 0.50trust 0.70ImmunityBio, Inc. +0.80ANKTIVA +0.80Food and Drug Administration +0.80+1 entities
2026-10-14 15:57:29 UTC#460319duplicateconfirmednews
ImmunityBio receives FDA approval for Anktiva in bladder cancer treatment
2026-08-10 13:02:00 UTC#152821newconfirmednews
ImmunityBio (IBRX) Appoints Patrick Soon-Shiong to Newly Created Office of Executive Chairman
2026-08-10 13:01:00 UTC#152828newconfirmedpress release
ImmunityBio Appoints Former World Bank President Jim Yong Kim as Vice Chairman
2026-08-04 12:33:20 UTC#122997updateconfirmednews
ImmunityBio Q2 adjusted loss of $0.22/share misses $0.09 estimate; revenue $51.24M beats $49.70M
2026-08-04 11:43:01 UTC#122695newconfirmednews
ImmunityBio Q2 2026 product revenue $50.7M, up 92% YoY; H1 revenue $94.8M with $357.4M cash
2026-07-30 21:23:01 UTC#105164newconfirmednews
ImmunityBio receives UAE marketing authorization for ANKTIVA in NMIBC and NSCLC
tradingviewimportance 0.50trust 0.90ImmunityBio, Inc. +0.60ANKTIVA +0.60Emirates Drug Establishment +0.40